PROTAGENIC THERAPEUTICS INC (PTIX) Stock Overview
NASDAQ:PTIX - US74365N2027 - Common Stock
PTIX Key Statistics, Chart & Performance
The current stock price of PTIX is 2.86 USD. In the past month the price increased by 4%. In the past year, price decreased by -74.14%.
PTIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.98 | 373.87B | ||
| AMGN | AMGEN INC | 12.77 | 149.94B | ||
| GILD | GILEAD SCIENCES INC | 14.89 | 143.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.94 | 99.62B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.52B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.18 | 58.91B | ||
| ARGX | ARGENX SE - ADR | 82.3 | 46.69B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.49 | 37.32B | ||
| INSM | INSMED INC | N/A | 30.85B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.28B | ||
| NTRA | NATERA INC | N/A | 23.30B | ||
| BIIB | BIOGEN INC | 8.91 | 20.91B |
Related stock screener links
About PTIX
Company Profile
Protagenic Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The firm has approximately six drug candidates targeting stress-related and CNS disorders, including treatments for obesity and metabolic disorders. The firm's pipeline includes PT-00114 in Phase I/IIa and five preclinical assets including PHYX-001, cannabinoid-based compounds, and modified stilbenoid assets. The PHYX-001 is a potassium channel modulator with a mechanism similar to XEN1101 and BHV-7000. The firm's cannabinoid assets include multiple cannabinoid-based compounds with composition-of-matter IP; potential in CNS, cardiometabolic, and other indications. The firm's cannabinoid assets also include a molecule with potential in the obesity, metabolic dysfunction sector, where the GLP-1 agonists have become medications. Its modified stilbenoid assets include modified stilbenoid compounds with composition-of-matter IP and anticonvulsant activity in preclinical models.
Company Info
PROTAGENIC THERAPEUTICS INC
149 Fifth Avenue, Suite 500
New York City NEW YORK 10010 US
CEO: Garo H. Armen
Employees: 1
Phone: 12129948200
PROTAGENIC THERAPEUTICS INC / PTIX FAQ
What is the stock price of PROTAGENIC THERAPEUTICS INC today?
The current stock price of PTIX is 2.86 USD.
What is the ticker symbol for PROTAGENIC THERAPEUTICS INC stock?
The exchange symbol of PROTAGENIC THERAPEUTICS INC is PTIX and it is listed on the Nasdaq exchange.
On which exchange is PTIX stock listed?
PTIX stock is listed on the Nasdaq exchange.
What is PROTAGENIC THERAPEUTICS INC worth?
PROTAGENIC THERAPEUTICS INC (PTIX) has a market capitalization of 2.49M USD. This makes PTIX a Nano Cap stock.
How many employees does PROTAGENIC THERAPEUTICS INC have?
PROTAGENIC THERAPEUTICS INC (PTIX) currently has 1 employees.
What are the support and resistance levels for PROTAGENIC THERAPEUTICS INC (PTIX) stock?
PROTAGENIC THERAPEUTICS INC (PTIX) has a support level at 2.84 and a resistance level at 3.27. Check the full technical report for a detailed analysis of PTIX support and resistance levels.
Should I buy PROTAGENIC THERAPEUTICS INC (PTIX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PTIX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PTIX, evaluating the profitability, health, valuation and growth aspects
- PROTAGENIC THERAPEUTICS INC (PTIX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PROTAGENIC THERAPEUTICS INC (PTIX) Sales and EPS estimates to see what analysts future expectations are.
- PROTAGENIC THERAPEUTICS INC (PTIX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PROTAGENIC THERAPEUTICS INC (PTIX) Insider and Institutional Ownership to learn about the owners and their transactions.
- PROTAGENIC THERAPEUTICS INC (PTIX) Stock Chart to make your own analysis
- PROTAGENIC THERAPEUTICS INC (PTIX) Latest news and press-releases to stay up to date.
Does PROTAGENIC THERAPEUTICS INC (PTIX) stock pay dividends?
PTIX does not pay a dividend.
When does PROTAGENIC THERAPEUTICS INC (PTIX) report earnings?
PROTAGENIC THERAPEUTICS INC (PTIX) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of PROTAGENIC THERAPEUTICS INC (PTIX)?
PROTAGENIC THERAPEUTICS INC (PTIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.31).
What is the Short Interest ratio of PROTAGENIC THERAPEUTICS INC (PTIX) stock?
The outstanding short interest for PROTAGENIC THERAPEUTICS INC (PTIX) is 5.54% of its float. Check the ownership tab for more information on the PTIX short interest.
PTIX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PTIX. When comparing the yearly performance of all stocks, PTIX is a bad performer in the overall market: 96.08% of all stocks are doing better.
PTIX Financial Highlights
Over the last trailing twelve months PTIX reported a non-GAAP Earnings per Share(EPS) of -13.31. The EPS increased by 30.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -530.09% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |